Balyasny Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.14M | Buy |
+96,371
| New | +$5.14M | 0.01% | 885 |
|
|
2025
Q1 | – | Sell |
-649,134
| Closed | -$18.1M | – | 1976 |
|
|
2024
Q4 | $18.1M | Buy |
+649,134
| New | +$18.1M | 0.03% | 536 |
|
|
2024
Q1 | – | Sell |
-198,271
| Closed | -$4.63M | – | 1947 |
|
|
2023
Q4 | $4.63M | Buy |
198,271
+158,988
| +405% | +$3.71M | 0.01% | 802 |
|
|
2023
Q3 | $1.99M | Sell |
39,283
-38,250
| -49% | -$1.93M | ﹤0.01% | 996 |
|
|
2023
Q2 | $3.62M | Buy |
+77,533
| New | +$3.62M | 0.01% | 860 |
|